why choose us

First received: December 22, 2022

Clinical Trial: Dual-Tracer Theranostic PET

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Neuroendocrine Tumors

Study Type: INTERVENTIONAL


Official Title: Dual-Tracer Theranostic PET

Brief Summary: This study is designed to obtain positron emission tomography with x-ray computed tomography (PET/CT) imaging data with each tracer pair, providing the imaging data needed to develop new simultaneous dual-tracer imaging techniques and processing algorithms for these tracer pairs.

Read more